 |
 |

Localized Prostate Cancer and DNA Ploidy
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their study of the long-term outcomes following conservative management of localized prostate cancer, Dr Albertsen and colleagues1 conclude that a Gleason score of 2 to 4 is a very good prognostic sign. However, the Gleason score is a highly subjective measure that is based on a pathologists perception of tissue patterns. A much more objective prognostic measure is the DNA content or ploidy of tumor cells.2-3
Carcinomas with normal, near-normal, or diploid DNA content are less aggressive and less likely to extend beyond the prostate than nondiploid (aneuploid) cancers.3-4 As recently suggested by Lorenzato et al,5 therapeutic decisions that depend on the extent of prostate cancer (organ-confined T1T2 or nonorgan-confined T3T4) can be helped by DNA analysis of the tumor, potentially reducing the rate of unnecessary radical prostatectomy with its attendant adverse effects of incontinence and impotence. For example, in patients with prostate-specific antigen levels of . . . [Full Text of this Article]
Leopold G. Koss, MD
lkoss@montefiore.org Montefiore Medical Center Bronx, NY
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Localized Prostate Cancer and DNA PloidyReply
Peter C. Albertsen, James A. Hanley, and Judith Fine
JAMA. 2005;294(10):1207-1208.
EXTRACT
| FULL TEXT
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Peter C. Albertsen, James A. Hanley, and Judith Fine
JAMA. 2005;293(17):2095-2101.
ABSTRACT
| FULL TEXT
|